Inclusion Criteria |
Age: 19–60 years |
Body mass index: 25.0–29.9 kg/m2 |
Signed written informed consent |
Exclusion Criteria |
Blood pressure ≥ 160/100 mmHg or treated with diuretics or β-blockers |
Fasting plasma glucose ≥126 mg/dL or treated with oral hypoglycemic agents or insulin |
Fasting serum triglyceride level > 600 mg/dL |
Serum AST or ALT level ≥ 3 times the upper limit of normal |
Serum creatinine level ≥ 1.5 times the upper limit of normal |
Thyroid-stimulating hormone ≤ 0.1 μU/mL or ≥ 10 μU/mL |
Use of drugs, herbs or supplements known to significantly affect body weight (anti-obesity agents, anti-depressant drugs, glucocorticoids, laxatives, oral contraceptives, female hormones, etc.) in the past 3 months |
Significant cardiac events within the past 6 months |
History of malignancy within the past 5 years |
Allergic disease, including bronchial asthma |
Cardiac disease, cerebrovascular disease, pulmonary disease, endocrine disease, renal disease, gout, porphyria |
Gastrointestinal disease, liver disease, gallbladder disease, pancreatic disease, malabsorption syndrome |
Psychiatric disorder, including major depression, schizophrenia, bulimia, alcohol abuse, or substance abuse |
History of abdominal adhesion after surgery |
History of obesity surgery |
Weight loss greater than 4 kg within the past 3 months |
Pregnant or breastfeeding women |
Women of childbearing age not adhering to acceptable forms of contraception |
Participants in another clinical trial within the past 1 month |